Re-emerging Disease: Monkeypox what you need to know

Posted on May 21, 2022

It’s everywhere in the media now days, that we are seeing a re-emergence of Monkeypox.  Monkeypox was first discovered by Von Magnus in Copenhagen Denmark in 1958 in captive monkeys. It wasn’t until 1970 that several cases were discovered in humans in Africa, mainly children under the age of 15. Sporadic human cases have appeared over the years worldwide but are centered mainly in Africa.

The Monkeypox virus belongs to the Orthopox family: Vaccinia (Smallpox vaccine), Variola (Smallpox), and Cowpox. Previously Smallpox vaccination was used to protect humans from Monkeypox and offered an 85% protection rate.  In the US the Smallpox vaccine has not been regularly given since about 1980. Many of us recognize the scars on our upper arms or thighs. A vaccine specifically used for Monkeypox had been developed and approved in 2013. It is a combo vaccine used for both Smallpox and Monkeypox , JYNNEOS {Bavarian Nordic} is the only FDA-approved non-replicating smallpox and monkeypox vaccine approved for non-military use and utilizes CHICK EMBRYO, not aborted fetal cell lines.

The following are the ethical vaccines which do not utilize Aborted Fetal Cell lines:

ACAM2000: Smallpox: VERO/Monkey cells
MVA3000: Smallpox: VERO/ Monkey Cells
JYNNEOS (IMVANEX®, Europe; IMVAMUNE®, Canada): Smallpox/Monkeypox: CHICK EMBRYO

We will be keeping a watchful eye as the situation unfolds.